Cintas (CTAS) CFO Granted 4,448 Shares & 17,755 Options
Scott Garula, VP & CFO of Cintas Corporation (CTAS), received equity awards on 08/11/2025.
Rhea-AI Filing Summary
Scott Garula, VP & CFO of Cintas Corporation (CTAS), received equity awards on 08/11/2025. The filing shows 4,448 restricted common shares were granted under Cintas's Equity Compensation Plan and 17,755 stock options were awarded with an exercise price of $223.88. Following the transactions, the report shows 98,007 common shares beneficially owned (direct) and 17,755 derivative securities (options) beneficially owned (direct). The options expire on 08/11/2035 and vest in three equal tranches: one-third on the third, fourth, and fifth anniversaries of the grant date. The filing also reports 19 shares held indirectly through a 401(k) plan.
Positive
- 4,448 restricted shares granted to Scott Garula under the Cintas Equity Compensation Plan
- 17,755 stock options granted with an exercise price of $223.88 and expiration on 08/11/2035
- Vesting schedule disclosed: options vest one-third on the third, fourth, and fifth anniversaries of the grant date
- Post-transaction holdings reported: 98,007 common shares (direct) and 17,755 options (direct)
Negative
- None.
Insights
TL;DR: Routine executive compensation grants; material to insider holdings but likely neutral for valuation absent other changes.
The Form 4 documents time-based equity compensation: 4,448 restricted shares and 17,755 options at a $223.88 exercise price. Post-transaction direct common holdings are reported as 98,007 shares and 17,755 options. These awards are standard long-term incentive instruments that increase the executive's stake but will only be dilutive if exercised; the option term through 08/11/2035 provides a long exercise window.
TL;DR: Standard vesting schedule ties pay to multi-year service; disclosure is clear on vesting and expiry but does not indicate performance conditions.
The option vesting is explicitly time-based: one-third at years three, four and five, which aligns payout to continued service rather than short-term performance. The filing specifies expiration date and exercise price, and notes the restricted shares are granted under the companys equity plan. No performance-based vesting or special acceleration is disclosed in the form.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,755 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 4,448 | $223.88 | $996K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan.
- F2. The option vests as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Form 4 for CTAS?
What securities did Scott Garula acquire on 08/11/2025?
What is the exercise price and term of the options in the CTAS filing?
How do the options vest according to the filing?
What are Garulas beneficial holdings after the reported transactions?
Are there any indirect holdings disclosed?
AI-generated analysis. How Rhea-AI works. Not financial advice.